Novel drug eluting stent system for customised treatment of coronary lesions : CUSTOM I feasibility trial 24 month results

The Custom NX 36 Drug Eluting Stent (DES) System is designed to treat coronary lesions via in situ stent length customisation. The stent evaluated in this study consists of nine interdigitated stent segments, each 4 mm in length, coated with a biodegradable formulation of Biolimus A9 and Poly-Lactic...

Full description

Saved in:

Bibliographic Details
Published in:	EuroIntervention Vol. 4; no. 1; pp. 71 - 76
Main Authors:	GRUBE, Eberhard, SIEVERT, Horst, HAUPTMANN, Karl-Eugen, MUELLER, Ralf, GERCKENS, Ulrich, BUELLESFELD, Lutz, AKO, Junya, SHIMOHAMA, Takao, COSTA, Marco, FITZGERALD, Peter
Format:	Journal Article
Language:	English
Published:	Toulouse Société Europa Edition 01-05-2008
Subjects:	Aged Angioplasty, Balloon, Coronary - adverse effects Biological and medical sciences Cardiology. Vascular system Coated Materials, Biocompatible Coronary Artery Disease - therapy Coronary heart disease Drug Delivery Systems Drug-Eluting Stents - adverse effects Feasibility Studies Female Follow-Up Studies Heart Humans Lactic Acid Male Medical sciences Middle Aged Polyesters Polymers Prospective Studies Sirolimus - administration & dosage Sirolimus - analogs & derivatives Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Treatment Outcome Treatment Biolimus A9 Coronary artery Cardiovascular disease Feasibility Lesion Coronary heart disease Drug eluting stent System customisation Result
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!